Cannabis Use and Psychosis – Modern Views on the Problem. Narrative Synthesis

Kolgashkin A. J.
Senior Researcher¹
ORCID 0000-0002-5592-4521

Nadezhdin A. V.
MD, PhD, Leading Researcher, Psychiatrist of the Consultative and Diagnostic Department¹; Assistant Professor²
ORCID 0000-0003-3368-3170

Tetenova E. J.
MD, PhD, Leading Researcher, Psychiatrist of the Consultative and Diagnostic Department¹
ORCID 0000-0002-9390-621X

Vdovin A. S.
MD, Head, Clinical Branch¹

Yusupov A. A.
MD, Head, Emergency Addiction Treatment Department¹

Sobornikova E. A.
MD, PhD, Psychotherapist¹; Assistant Professor²

Alekseyuk V. V.
MD, Psychiatrist-Addiction Doctor, Emergency Addiction Treatment Department¹
ORCID 0000-0002-6882-6875

Andryushin D. A.
MD, Psychiatrist-Addiction Doctor, Emergency Addiction Treatment Department¹

Barsukova A. A.
MD, Psychiatrist, Emergency Addiction Treatment Department¹

Deresh S. V.
MD, Psychiatrist-Addiction Doctor, Emergency Addiction Treatment Department¹

Zajceva A. V.
MD, Psychiatrist-Addiction Doctor, Emergency Addiction Treatment Department¹

Zverkov P. P.
MD, Psychiatrist-Addiction Doctor, Emergency Addiction Treatment Department¹

Nadezhdin S. A.
MD, Researcher¹

Nenasheva A. S.
MD, Psychiatrist-Addiction Doctor, Emergency Addiction Treatment Department¹

Sivcov I. G.
Psychiatrist-Addiction Doctor, Emergency Addiction Treatment Department¹

Sobolev S. S.
Psychiatrist-Addiction Doctor, Emergency Addiction Treatment Department¹

1 - Moscow Research and Practical Centre on Addictions of Moscow Department of Public Health, Moscow, Russian Federation
2 - Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation

Kolgashkin Alexey; e-mail: krambol15@mail.ru

None declared.

The study had no sponsorship.

Cannabis continues to be the most widely used drug worldwide. Recently, there has been two trends in the field: a liberalization of cannabis-related legislation in a number of countries, as well as an increase in the content of the psychoactive component in cannabis plant – tetrahydrocannabinol. The review covers a topic that has been little studied in Russian addiction science – cannabis use and associated psychotic disorders. Research materials: publications in the Pubmed and RSCI databases. Topics addressed include: cannabis use and psychotic disorders; alternative views on the causal relationship between cannabis use and psychotic disorders; gender specifics in the development of psychotic disorders; genetic predisposition to the development of psychotic disorders in cannabis users; problems with cannabis use in adolescence; possible reasons for using cannabis; suicidal behavior of cannabis users; relationship between cannabis and tobacco use; clinical aspects of treating cannabis users with psychotic disorders; promising areas of future studies. In the absence of domestic research on these topics, such a brief review may help addiction doctors to get a general idea of the modern state of the problem.

cannabis, psychosis, schizophrenia, tetrahydrocannabinol, cannabidiol, psychotic disorders

10.29234/2308-9113-2021-9-4-76-100

1. UNODC World Drug Report 2021. Drug Market Trends: Cannabis, Opioids; United Nations publication, Sales No. E.21.XI.8, 2021; ISBN 9789211483611.

2. European Monitoring Centre for Drugs and Drug Addiction European Drug Report 2019: Trends and Developments; Publications Office of the European Union: Luxembourg, 2019; ISBN 9789294974457.

3. Freeman T.P., Lorenzetti V. ‘Standard THC Units’: A Proposal to Standardize Dose across All Cannabis Products and Methods of Administration. Addiction 2020, 115, 1207-1216, doi: 10.1111/add.14842.

4. UNODC World Drug Report 2021. Executive Summary. Policy Implications; United Nations publication, Sales No. E.21.XI.8, 2021; ISBN 9789211483611.

5. Hasin D., Walsh C. Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review. Journal of Clinical Medicine 2021, doi: 10.3390/jcm100.

6. Murray R.M., Englund A., Abi-Dargham A., Lewis D.A., di Forti M., Davies C., Sherif M., McGuire P., D’Souza D.C. Cannabis-Associated Psychosis: Neural Substrate and Clinical Impact. Neuropharmacology 2017, 124, 89-104, doi: 10.1016/j.neuropharm.2017.06.018.

7. Wright A., Cather C., Gilman J., Evins A.E. The Changing Legal Landscape of Cannabis Use and Its Role in Youth-Onset Psychosis. Child and Adolescent Psychiatric Clinics of North America 2020, 29, 145-156, doi: 10.1016/j.chc.2019.08.016.

8. Hamilton I., Sumnall H. Are We Any Closer to Identifying a Causal Relationship between Cannabis and Psychosis? Current Opinion in Psychology 2021, 38, 56-60, doi: 10.1016/j.copsyc.2020.07.027.

9. Lowe D.J.E., Sasiadek J.D., Coles A.S., George T.P. Cannabis and Mental Illness: A Review. European Archives of Psychiatry and Clinical Neurosciense 2019, 269, 107-120, doi: 10.1007/s00406-018-0970-7.

10. Bonaccorso S., Ricciardi A., Zangani C., Chiappini S., Schifano F. Cannabidiol (CBD) Use in Psychiatric Disorders: A Systematic Review. NeuroToxicology 2019, 74, 282-298, doi: 10.1016/j.neuro.2019.08.002.

11. Hindley G., Beck K., Borgan F., Ginestet C.E., McCutcheon R., Kleinloog D., Ganesh S., Radhakrishnan R., D’Souza D.C., Howes O.D. Psychiatric Symptoms Caused by Cannabis Constituents: A Systematic Review and Meta-Analysis. The Lancet Psychiatry 2020, 7, 344-353, doi: 10.1016/S2215-0366(20)30074-2.

12. Colizzi M., Murray R. Cannabis and Psychosis: What Do We Know and What Should We Do? British Journal of Psychiatry 2018, 212, 195-196, doi: 10.1192/bjp.2018.1.

13. Lafaye G., Karila L., Blecha L., Benyamina A. Cannabis, Cannabinoids, and Health. Dialogues in Clinical Neuroscience 2017, 19, 309-316, doi: 10.31887/dcns.2017.19.3/glafaye.

14. Sideli L., Quigley H., la Cascia C., Murray R.M. Cannabis Use and the Risk for Psychosis and Affective Disorders. Journal of Dual Diagnosis 2020, 16, 22-42, doi: 10.1080/15504263.2019.1674991.

15. Hamilton I. Cannabis, Psychosis and Schizophrenia: Unravelling a Complex Interaction. Addiction 2017, 112, 1653-1657, doi: 10.1111/add.13826.

16. Kirzhanova V.V., Grigorova N.I., Bobkov E.N., Kirzhanov V.N., Sidoryuk O.V. Deyatel'nost' narkologicheskoj sluzhby Rossijskoj Federacii v 2019-2020 godah: Analiticheskij obzor. [Activities of the Narcological Service of the Russian Federation in 2019-2020: Analytical Review]; FSBI «NMITs PN im. V.P. Serbsky» of the Ministry of Health of Russia: Moscow, 2021. ISBN 9785860023291. (In Russ.)

17. Andreasson S., Allebeck P., Engstrom A., Rydberg U. Cannabis and Schizophrenia. A Longitudinal Study of Swedish Conscripts. The Lancet 1987, 2, 1483-1486.

18. Farris M.S., Shakeel M.K., Addington J. Cannabis Use in Individuals at Clinical High-Risk for Psychosis: A Comprehensive Review. Social Psychiatry and Psychiatric Epidemiology 2020, 55, 527-537, doi: 10.1007/s00127-019-01810-x.

19. Hjorthoj C., Larsen M.O., Starzer M.S.K., Nordentoft M. Annual Incidence of Cannabis-Induced Psychosis, Other Substance-Induced Psychoses and Dually Diagnosed Schizophrenia and Cannabis Use Disorder in Denmark from 1994 to 2016. Psychological Medicine 2021, 51, 617-622, doi: 10.1017/S0033291719003532.

20. Pearson N.T., Berry J.H. Cannabis and Psychosis through the Lens of DSM-5. International Journal of Environmental Research and Public Health 2019, 16, doi: 10.3390/ijerph16214149.

21. Hamilton I., Monaghan M. Cannabis and Psychosis: Are We Any Closer to Understanding the Relationship? Current Psychiatry Reports 2019, 21, 48, doi: 10.1007/s11920-019-1044-x.

22. Patel S., Khan S., Hamid P. The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review. Cureus 2020, doi: 10.7759/cureus.9309.

23. Nielsen S.M., Toftdahl N.G., Nordentoft M., Hjorthoj C. Association between Alcohol, Cannabis, and Other Illicit Substance Abuse and Risk of Developing Schizophrenia: A Nationwide Population Based Register Study. Psychological Medicine 2017, 47, 1668-1677, doi: 10.1017/S0033291717000162.

24. Sánchez-Gutiérrez T., Fernandez-Castilla B., Barbeito S., González-Pinto A., Becerra-García J.A., Calvo A. Cannabis Use and Nonuse in Patients with First-Episode Psychosis: A Systematic Review and Meta-Analysis of Studies Comparing Neurocognitive Functioning. European Psychiatry 2019, 63, e6, 1-10, doi: 10.1192/j.eurpsy.2019.9.

25. van der Steur S.J., Batalla A., Bossong M.G. Factors Moderating the Association between Cannabis Use and Psychosis Risk: A Systematic Review. Brain Sciences 2020, 10, doi: 10.3390/brainsci10020097.

26. Rentero D., Arias F., Sánchez-Romero S., Rubio G., Rodríguez-Jiménez R. Cannabis-Induced Psychosis: Clinical Characteristics and Its Differentiation from Schizophrenia with and without Cannabis Use. Adicciones 2021, 33, 95-108, doi: 10.20882/adicciones.1251.

27. di Forti M., Quattrone D., Freeman T.P., Tripoli G., Gayer-Anderson C., Quigley H., Rodriguez V., Jongsma H.E., Ferraro L., la Cascia C., et al. The Contribution of Cannabis Use to Variation in the Incidence of Psychotic Disorder across Europe (EU-GEI): A Multicentre Case-Control Study. The Lancet Psychiatry 2019, 6, 427-436, doi: 10.1016/S2215-0366(19)30048-3.

28. Shah D., Chand P., Bandawar M., Benegal V., Murthy P. Cannabis Induced Psychosis and Subsequent Psychiatric Disorders. Asian Journal of Psychiatry 2017, 30, 180-184, doi: 10.1016/j.ajp.2017.10.003.

29. Ivan Urits B., Gress K., Charipova K., Li N., Berger A.A., Cornett E.M., Hasoon J., Kassem H., Kaye A.D., Viswanath O., et al. Cannabis Use and Its Association with Psychological Disorders. PsychoPharmacology Bulletin 2020, 56, 56-66.

30. Patten S.B. Cannabis and Non-Psychotic Mental Disorders. Current Opinion in Psychology 2021, 38, 61-66, doi: 10.1016/j.copsyc.2020.09.006.

31. Ortiz-Medina M.B., Perea M., Torales J., Ventriglio A., Vitrani G., Aguilar L., Roncero C. Cannabis Consumption and Psychosis or Schizophrenia Development. International Journal of Social Psychiatry 2018, 64, 690-704, doi: 10.1177/0020764018801690.

32. Hasan A., von Keller R., Friemel C.M., Hall W., Schneider M., Koethe D., Leweke F.M., Strube W., Hoch E. Cannabis Use and Psychosis: A Review of Reviews. European Archives of Psychiatry and Clinical Neuroscience 2020, 270, 403-412, doi: 10.1007/s00406-019-01068-z.

33. Beckmann D., Lowman K.L., Nargiso J., McKowen J., Watt L., Yule A.M. Substance-Induced Psychosis in Youth. Child and Adolescent Psychiatric Clinics of North America 2020, 29, 131-143, doi: 10.1016/j.chc.2019.08.006.

34. Setién-Suero E., Neergaard K., Ortiz-García de la Foz V., Suárez-Pinilla P., Martínez-García O., Crespo-Facorro B., Ayesa-Arriola R. Stopping Cannabis Use Benefits Outcome in Psychosis: Findings from 10-Year Follow-up Study in the PAFIP-Cohort. Acta Psychiatrica Scandinavica 2019, 140, 349-359, doi: 10.1111/acps.13081.

35. Coronado-Montoya S., Morissette F., Abdel-Baki A., Fischer B., Côté J., Ouellet-Plamondon C., Tremblay L., Jutras-Aswad D. Preventive Interventions Targeting Cannabis Use and Related Harms in People with Psychosis: A Systematic Review. Early Intervention in Psychiatry 2021, 15, 1439-1453, doi: 10.1111/eip.13081.

36. Matsumoto T., Kawabata T., Okita K., Tanibuchi Y., Funada D., Murakami M., Usami T., Yokoyama R., Hashimoto N., Fujita O., et al. Risk Factors for the Onset of Dependence and Chronic Psychosis Due to Cannabis Use: Survey of Patients with Cannabis-Related Psychiatric Disorders. Neyropsychopharmacol Rep. 2020, 40, 332-341, doi: 10.1002/npr2.12133.

37. Johnson-Ferguson L., di Forti M. From Heavy Cannabis Use to Psychosis: Is It Time to Take Action? Irish Journal of Psychological Medicine 2021, 1-6, doi: 10.1017/ipm.2021.33.

38. Fekih-Romdhane F., Hakiri A., Fadhel S. ben, Cheour M. Cannabis Use in Subjects at Ultra High Risk for Psychosis. Presse Medicale 2019, 48, 1229-1236, doi: 10.1016/j.lpm.2019.09.030.

39. Weiss S.R.B., Blanco C., Wargo E.M. Clarifying the Link between Cannabis Use and Risk for Psychosis. Acta Psychiatr Scand. 2017, 136, 3-4, doi: 10.1111/acps.12764.

40. Moulin V., Alameda L., Framorando D., Baumann P.-S., Gholam M., Gasser J., do Cuenod K.-Q., Conus P. Early Onset of Cannabis Use and Violent Behavior in Psychosis. European Psychiatry 2020, 63, 1-8, doi: 10.1192/j.eurpsy.2020.71.

41. Mustonen A., Niemelä S., Nordström T., Murray G.K., Mäki P., Jääskeläinen E., Miettunen J. Adolescent Cannabis Use, Baseline Prodromal Symptoms and the Risk of Psychosis. British Journal of Psychiatry 2018, 212, 227-233, doi: 10.1192/bjp.2017.52.

42. Jones J.D., Calkins M.E., Scott J.C., Bach E.C., Gur R.E. Cannabis Use, Polysubstance Use, and Psychosis Spectrum Symptoms in a Community-Based Sample of U.S. Youth. Journal of Adolescent Health 2017, 60, 653-659, doi: 10.1016/j.jadohealth.2017.01.006.

43. Kiburi S.K., Molebatsi K., Ntlantsana V., Lynskey M.T. Cannabis Use in Adolescence and Risk of Psychosis: Are There Factors That Moderate This Relationship? A Systematic Review and Meta-Analysis. Substance Abuse 2021, 42, 527-542, doi: 10.1080/08897077.2021.1876200.

44. Gobbi G., Atkin T., Zytynski T., Wang S., Askari S., Boruff J., Ware M., Marmorstein N., Cipriani A., Dendukuri N., et al. Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood A Systematic Review and Meta-Analysis Supplemental Content. JAMA Psychiatry 2019, 76, 426-434, doi: 10.1001/jamapsychiatry.2018.4500.

45. Hurd Y.L., Olivier X., Manzoni J., Pletnikov M.V., Lee F.S., Bhattacharyya S., Melis M. Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects. The Journal of Neuroscience 2019, 39, 8250-8258, doi: 10.1523/JNEUROSCI.1165-19.2019.

46. Hosseini S., Oremus M. The Effect of Age of Initiation of Cannabis Use on Psychosis, Depression, and Anxiety among Youth under 25 Years. Canadian Journal of Psychiatry 2019, 64, 304-312, doi: 10.1177/0706743718809339.